PFE Operating Cash Flow Growth
Pfizer · Operating Cash Flow Growth
PFE Operating Cash Flow Growth
Year-over-year change vs the same period a year earlier
Latest reported243.47%period ending
PFE Quarterly Cash from Operations YoY % (-31.34% → 243.47%)
Year-over-year change
High-resolution chart · PNG
PFE operating cash flow growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow Growth |
|---|---|
| 243.4708% | |
| 11.9914% | |
| -20.4136% | |
| -31.4418% | |
| 67.3217% | |
| 114.2202% | |
| 28.2634% | |
| 94.2708% | |
| -47.3118% | |
| -10.1401% | |
| -38.942% | |
| -42.1493% | |
| -114.7999% | |
| -81.4554% | |
| 45.1133% | |
| -44.8333% | |
| -27.7016% | |
| 44.1384% | |
| 5.1378% | |
| 418.134% | |
| 217.834% | |
| 44.8452% | |
| 49.2438% | |
| -53.6585% | |
| 36.1547% | |
| 84.5112% | |
| -20.4517% | |
| -14.2423% | |
| -32.1289% | |
| -14.3722% | |
| -29.7241% | |
| 7.612% | |
| 18.2964% | |
| 24.7955% | |
| 12.8935% | |
| 4.0009% | |
| -9.1366% | |
| -3.7553% | |
| 26.7133% | |
| -6.4689% | |
| -12.4939% | |
| 141.0219% | |
| -12.6899% | |
| 12.57% | |
| 0.0734% | |
| -76.661% | |
| -6.7058% | |
| -24.4584% | |
| 6.7102% | |
| 30.9683% | |
| 10.0837% | |
| 18.0891% | |
| -4.7501% | |
| -19.2141% | |
| -0.095% | |
| 12.7056% | |
| -31.8243% | |
| -40.2413% | |
| -15.9316% | |
| -33.5777% | |
| 21.0343% | |
| 172.9874% | |
| 29.6995% | |
| 62.9603% | |
| 7.953% | |
| -302.0972% | |
| -19.2198% | |
| 3.7702% | |
| -10.472% | |
| -3.7909% | |
| 58.5612% | |
| -15.5195% | |
| 37.5716% | |
| 163.1537% | |
| -15.84% | |
| 16.5421% | |
| -28.7381% | |
| -68.619% | |
| -5.5098% | |
| 33.2227% | |
| 35.0223% | |
| 24.7952% | |
| -20.9182% | |
| -41.789% | |
| 6.0707% | |
| 100.5054% | |
| 36.2602% | |
| 80.1601% | |
| 68.3544% | |
| -32.2636% | |
| 17.729% | |
| 24.1037% | |
| -16.6797% | |
| 48.4752% | |
| 50.9907% | |
| -10.2713% | |
| 6.8447% | |
| -13.2304% | |
| -6.6792% | |
| 21.5261% |